Long-term ethanol exposure inhibits glucose transporter 4 expression via an AMPK-dependent pathway in adipocytes

Li Feng1, Yong-feng Song, Qing-bo Guan

  • 1Provincial Hospital Affiliated to Shandong University, Institute of Endocrinology, Shandong Academy of Clinical Medicine, Ji-nan, China.

Acta Pharmacologica Sinica
|February 23, 2010
PubMed
Abstract

Insights

Ethanol consumption impairs glucose regulation by inhibiting the AMPK/MEF2/GLUT4 pathway in adipocytes, reducing glucose transporter 4 (GLUT4) expression and insulin sensitivity.

Area of Science:

  • Metabolic signaling pathways
  • Cellular response to ethanol
  • Glucose homeostasis

Background:

  • The AMP-activated protein kinase (AMPK) and myocyte enhancer factor 2 (MEF2) isoforms' roles in ethanol's effects on glucose transporter 4 (GLUT4) are not fully understood.
  • Investigating these molecular mechanisms is crucial for understanding ethanol-induced metabolic dysfunction.

Purpose of the Study:

  • To elucidate the roles of AMPK and MEF2 isoforms in mediating ethanol's impact on GLUT4 expression in adipocytes.
  • To investigate the in vivo and in vitro effects of ethanol on the AMPK/MEF2/GLUT4 pathway.

Main Methods:

  • Male Wistar rats received daily ethanol doses (0, 0.5, or 5 g/kg) for 22 weeks, with AMPK, MEF2 (A and D), and GLUT4 expression analyzed.
  • Experiments in isolated rat and human adipocytes involved treatments with ethanol, AICAR (AMPK activator), and compound C (AMPK inhibitor).
  • Gene and protein expression levels were quantified using RT-PCR and Western blotting.

Main Results:

  • Long-term ethanol exposure significantly reduced activated AMPK, MEF2A, MEF2D, and GLUT4 expression in rat adipose tissue.
  • In adipocytes, compound C blocked AICAR-induced AMPK activation and subsequent increases in MEF2 and GLUT4 expression.
  • In vitro ethanol treatment suppressed the AMPK/MEF2/GLUT4 signaling pathway.

Conclusions:

  • The AMPK/MEF2/GLUT4 pathway is present in rat and human adipocytes, with activated AMPK positively regulating MEF2 and GLUT4.
  • Ethanol disrupts this pathway, leading to decreased GLUT4 expression, impaired insulin sensitivity, and reduced glucose tolerance.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...